SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122383
Filing Date
2024-11-06
Accepted
2024-11-06 16:30:21
Documents
56
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q onct-20240930.htm   iXBRL 10-Q 1483157
2 EX-31.1 onct-ex31_1.htm EX-31.1 15822
3 EX-31.2 onct-ex31_2.htm EX-31.2 15805
4 EX-32.1 onct-ex32_1.htm EX-32.1 8051
5 EX-32.2 onct-ex32_2.htm EX-32.2 8116
  Complete submission text file 0000950170-24-122383.txt   6458813

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onct-20240930.xsd EX-101.SCH 930644
58 EXTRACTED XBRL INSTANCE DOCUMENT onct-20240930_htm.xml XML 1102506
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 241431520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)